Celularity (CELU) Receivables - Other (2020 - 2024)
Celularity (CELU) posted quarterly Receivables - Other of $2.1 million for Q1 2024, down 2.03% year-over-year from $2.1 million in Q2 2023, and little changed quarter-over-quarter from $2.1 million in Q4 2023.
Celularity (CELU) Receivables - Other (2020 - 2024) Analysis & Trends
Celularity (CELU) has reported Receivables - Other for 5 consecutive years, with $2.1 million the latest figure, recorded in Q1 2024.
- In Q1 2024, Receivables - Other fell 2.03% year-over-year to $2.1 million; the TTM figure through Mar 2024 stood at $2.1 million (down 2.03% YoY), while the FY2023 annual figure was $2.1 million, down 17.58% from the prior year.
- Receivables - Other held at $2.1 million in Q1 2024 per CELU's latest filing, from $2.1 million in the prior quarter.
- Across five years, Receivables - Other topped out at $5.4 million in Q4 2020 and bottomed at $2.1 million in Q2 2023.
- Historically, Receivables - Other has averaged $2.9 million across 5 years, with a median of $2.4 million in 2021.
- Annual changes were most pronounced in 2021 — Receivables - Other plunged 54.06% — and 2022, when it grew 1.05%.
- Celularity's Receivables - Other stood at $5.4 million in 2020, then slumped by 54.06% to $2.5 million in 2021, then advanced by 1.05% to $2.5 million in 2022, then dropped by 17.58% to $2.1 million in 2023, then changed by 0.0% to $2.1 million in 2024.
- Business Quant data shows CELU's Receivables - Other at $2.1 million in Q1 2024, $2.1 million in Q4 2023, and $2.1 million in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Celularity | 20.99 Mn | 14.82 Mn | -3.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2024 | 2.07 Mn |
| Mar 31, 2024 | 2.07 Mn |
| Dec 31, 2023 | 2.07 Mn |
| Dec 31, 2023 | 2.07 Mn |
| Sep 30, 2023 | 2.07 Mn |
| Sep 30, 2023 | 2.07 Mn |
| Jun 30, 2023 | 2.07 Mn |
| Jun 30, 2023 | 2.07 Mn |
| Mar 31, 2023 | 2.12 Mn |
| Mar 31, 2023 | 2.12 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Dec 31, 2022 | 2.51 Mn |
| Sep 30, 2022 | 3.92 Mn |
| Sep 30, 2022 | 3.92 Mn |
| Jun 30, 2022 | 2.70 Mn |
| Jun 30, 2022 | 2.70 Mn |
| Mar 31, 2022 | 2.39 Mn |
| Mar 31, 2022 | 2.39 Mn |
| Dec 31, 2021 | 2.49 Mn |
| Dec 31, 2021 | 2.49 Mn |